Cancer Profiling Market Size, Share, Analysis with a CAGR of 11.5% (2024-30)

Global Cancer Profiling Market Overview:

MarkNtel Advisors has recently published a detailed research report on the Global Cancer Profiling Market. The report is specifically tailored to offer valuable insights and support for clients navigating this dynamic market. It focuses on key objectives such as predicting trends, gaining a profound understanding of market perspectives, identifying strategic investment opportunities, and evaluating potential business partners.

Cancer Profiling Market Insights and Analysis

The Global Cancer Profiling Market size is projected to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30. Our comprehensive report provides a thorough examination of market players, opportunities, and valuable insights, equipping our clients with the indispensable information needed to make well-informed decisions within this dynamically evolving environment.

Access the detailed PDF Sample report - https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html

Insights into Dominant Segments in the Cancer Profiling Market

By analysing each Segments, including

-By Application

Oncology Research
Precision Medicine
Clinical Diagnostics
Others (Prognosis, Monitoring and Recurrence Detection, etc.)

Within this group, oncology research acquires a major share of the Global Cancer Profiling Market. The rising prevalence of chronic cancer diseases, such as breast cancer, prostate cancer, etc., has been propelling pharmaceutical companies & biotech companies like Takeda, Pfizer, etc., to advance their research & development of new drugs & therapies. As a result, the demand for tumor profiling tests has been increasing since these testing services are used at various stages of drug development, such as preclinical testing, clinical trials, and others.

Moreover, the growing need to evaluate the safety & efficacy of these new drugs is also augmenting the requirement for reliable & accurate cancer profiling services. Hence, the rising growth in oncology research for drug development in the biopharmaceutical industry owing to an increasing focus on precision medicine has been driving the Global Cancer Profiling Market.

Further, pharmaceutical companies such as Merck KGaA, Sanofi, etc., are collaborating to develop drugs to minimize or reduce the growing instance of cancer, which would further boost the growth of this segment in cancer profiling market share to support the development & commercialization of these new drugs.

-By Type of Cancer

Breast Cancer - Market Size & Forecast 2019-2030, USD Million
Colorectal Cancer - Market Size & Forecast 2019-2030, USD Million
Gynecological Cancer - Market Size & Forecast 2019-2030, USD Million
‎Leukemia - Market Size & Forecast 2019-2030, USD Million
Prostate Cancer - Market Size & Forecast 2019-2030, USD Million
Lung Cancer - Market Size & Forecast 2019-2030, USD Million
Others (Pancreatic Cancer, Skin Cancer, etc.) - Market Size & Forecast 2019-2030, USD Million

-By Technology

Next-Generation Sequencing - Market Size & Forecast 2019-2030, USD Million
Polymerase Chain Reaction - Market Size & Forecast 2019-2030, USD Million
Mass Spectrometry - Market Size & Forecast 2019-2030, USD Million
In-Situ Hybridization - Market Size & Forecast 2019-2030, USD Million
Microarrays Analysis - Market Size & Forecast 2019-2030, USD Million
Others (Single-Cell Sequencing, etc.) - Market Size & Forecast 2019-2030, USD Million

-By Biomarker Type

Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Cell Type

Germline - Market Size & Forecast 2019-2030, USD Million
Somatic - Market Size & Forecast 2019-2030, USD Million

-By End-User

Hospitals and Clinics - Market Size & Forecast 2019-2030, USD Million
Research Institutions and Laboratories - Market Size & Forecast 2019-2030, USD Million
Diagnostic Service Providers - Market Size & Forecast 2019-2030, USD Million
Pharmaceutical and Biotechnology Companies - Market Size & Forecast 2019-2030, USD Million

Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/cancer-profiling-market.html

Cancer Profiling Market Geographical Reach:

The Cancer Profiling Market Geographical Reach assesses the distribution and prominence of consumption, highlighting regions that dominate in terms of market size, volume, and promising future growth prospects.

-By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

Clients can concentrate their investments on the segments that present the most favourable prospects. This strategic methodology empowers clients to fine-tune their investment portfolio and attain enduring growth within the Cancer Profiling market.

Current Landscape of Cancer Profiling Market

The key players profiled in the research report are

NeoGenomics Laboratories
Eurofins Genomics GmbH
Hoffmann-La Roche Ltd (Foundation Medicine)
OncoDNA SA
10x Genomics, Inc.
Caris Life Sciences.
Geneseeq Technology Inc.
Genetron Holdings Limited
Laboratory Corporation of America Holdings (LabCorp)
Dante Labs Inc.
Celemics, Inc.
Strand Life Sciences
Myriad Genetics, Inc.
QIAGEN GmbH
Tempus Labs
Others

In light of the ongoing rapid transformations within the Cancer Profiling market, retaining a strategic advantage is paramount for both businesses and investors. At MarkNtel Advisors, we exactly identify and study every notable player, taking into account their recent product launches, mergers, acquisitions, and collaborations. This thorough analysis assists our clients in making more accurate projections and staying competitive in the market.

Customization of Reports Available - https://www.marknteladvisors.com/query/request-customization/cancer-profiling-market.html

Global Cancer Profiling Industry Recent Development:

2023: Caris Life Sciences, a leading molecular science and healthcare innovation company announced that it is conducting four studies covering 14 tumor types, which would allow leveraging blood for precise cancer detection, monitoring, and therapy selection. These discoveries are significant observations, especially in the context of endometrial and prostate cancer.
2023: F. Hoffmann-La Roche Ltd (Foundation Medicine) and Natera have introduced an early access program for FoundationOne Tracker, a personalized ctDNA monitoring assay. FoundationOne Tracker, when used alongside imaging, can provide a more comprehensive assessment of treatment response, especially in cases where imaging results are unclear.

Cancer Profiling Market Future Prospects

The outlook for Cancer Profiling appears favourable in terms of both revenue share and sales, as evidenced by the market trends observed in the historical period, 2023-30. Anticipating continued robust growth over the next five years, market participants are expected to further bolster their portfolios by harnessing technological advancements within the industry. Adding to the market's attractiveness is the widespread application of the product/service across various end-users, allowing market players to establish a solid presence across continents.

Frequently Asked Questions

What predictions can be formulated concerning market share, product accessibility, and consumer demand?

What pivotal factors are influencing the dynamics of the Cancer Profiling Market?

What lies ahead in terms of future opportunities for the Cancer Profiling Market?

What obstacles are businesses encountering as they navigate the Cancer Profiling Market?

Who are the prominent players driving developments in the Cancer Profiling Market?

Related Reports

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15.98 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India